Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081596 | SCV000113527 | benign | not specified | 2013-08-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000081596 | SCV000167799 | benign | not specified | 2013-01-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000081596 | SCV000247062 | benign | not specified | 2018-12-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001085366 | SCV000563255 | benign | Cortical dysplasia-focal epilepsy syndrome | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000711330 | SCV000841671 | likely benign | not provided | 2017-11-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316254 | SCV000850086 | likely benign | Inborn genetic diseases | 2016-03-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000711330 | SCV005226901 | likely benign | not provided | criteria provided, single submitter | not provided |